Member Info for Shakeyerbooty

Shooting up.No slow & steady here lol.

Dipped my toe in whilst all the attention is on AD4.

Well,in the recent podcast with JW,Alan Green does mention that we are well funded with 2 million in the bank.

goooba769-As previously stated look at box 9 on RNS.

Jarv-that addressable market was based on getting just 1 gram per day into products in just 350m households per year.Imagine if we get more than 1 gram per day.The potential market here is huge.

Well funded with 2 million in the bank.Niche player with partnerships with the big guys.This should break 2p soon.

Thanks for posting Prosper88.Absolutely huge market.Suggest everyone reads this report.
Based on the comparative and unique properties of Itaconix polymers versus the acrylic acid market, we estimate a total addressable market for Itaconix products of US$7.6 billion.

Sorry,no,but based on that,the restructuring,funding done,£18m invoiced revenue Jan-June,the close relationship with Allay (UK) and the recent directors daughter purchase makes me believe that this is a screaming buy.Traffic on here and the other site is getting busier with more people seemingly buying in tells me this is coming onto more people's radars.

14th June RNS
4. Use of proceeds

Assuming all the Subscription Shares are issued, the net proceeds of the Subscription (which is expected to be approximately £1.87 million) will be used to fund the expected costs of the restructuring and to provide working capital to support the reshaped business into late 2020, assuming receipt of a significant research and development tax rebate in the third quarter of 2019.

We are also awaiting a significant research & development tax rebate this quarter.

Seems like a pre-news shake to me.

Almost blue.Very quiet here considering two billionaire investors have come on board.Everyone waiting to see who the two new board members are?

LB28-You've previously stated that you felt it should never have dropped below 6p.You've also stated that you felt on FDA approval it would go up much more than 70% (you were comparing to STX).Clearly you feel that on FDA approval this should be in double figures.The more people that research this co. and its markets,the more they are realising the future potential here just as you did..As Tra1 states,the small free float will play a part.We are now funded for accelerated growth via the CorTech Labs agreement and as DS has recently stated we are ready to go as soon as FDA approval is given.

Free float certainly getting smaller.There were also plenty of 75k buys last Thurs & Fri.

One noticeable thing in the last three trading days is that the number of trades has substantially increased.Spread has tightened as well.Looks like the MM's want to play.

Hark at BB with its crystal ball.What we will have with FDA approval is access to the worlds biggest medical devices market worth billions.In CorTech labs we have the partner & sales force trained,primed and ready to go.Funding has been done.Sales already stated to more than double this year.IQAI is not just about SC.With our small m/c and low free float,I expect a sharp incline upwards in our share price in the next few weeks/months/years.DS has form.

Very true Hedgehog100.Have seen your excellent posts over on the other site.Any chance you could post some of them over here?

1)Sales already stated to double this year compared to last.
2)Funding in place to accelerate development of IB products & StoneChecker
3)DS is checking his mailbox daily for FDA approval of SC
4)CorTech Labs are fully trained,primed & ready to go to immediately start selling SC in the USA
5)SC already has NICE approval & is being sold in the UK,Switzerland,South Korea etc
6)Michael Billig,whom DS has known for 10 yrs has a 100% record of getting FDA product approvals.
7)There is a huge gadolinium free market out there currently up to $2bn per annum in the US
8)Details of SC sent to 750 European urologists for a free 30 day trial.
9)Main market listed
10) Small free float and m/c
11)DS has a track record of building companies up and selling them

There are probably lots of other points for newbies to consider.Hope this helps.

Thanks Bertie & david.Even DS is checking his mail box daily,waiting impatiently.CorTechs Labs are trained,primed & ready to go immediately.DS has known Michael Billig,who has close links with the FDA and a 100% record of getting approvals,for 10 years.Details of StoneChecker sent to 750 European neurologists asking them to compare to existing treatment.DS not hanging around here and sounds supremely confident.The RNS will come before FDA publish it as FDA do a weekly report on a Monday,so literally could come anytime.

If that's the case david,at least you got to watch it.Any key points you'd like to share?